Type
Declercq E. Leprosy statistics 2009: some thoughts. Leprosy review [Internet]. 2011;82(1):87-9. Available from: https://leprosyreview.org/article/82/1/08-7089
View
Type
Dockrell H, Geluk A, Brennan P, Saunderson P, Oskam L, Lockwood DN, et al. Report on the sixth meeting of the IDEAL (Initiative for Diagnostic and Epidemiological Assays for Leprosy) consortium held in Beijing, China on 23-25 August 2010. Leprosy review [Internet]. 2011;82(1):80-5. Available from: https://leprosyreview.org/article/82/1/08-0085
View
Type
Chichava, Ariza, Oliveira, Ferreira, Da Silva M, Barbosa, et al. Reasons for interrupting multidrug therapy against leprosy: the patients' point of view. Leprosy review [Internet]. 2011;82(1):78-9. Available from: https://leprosyreview.org/article/82/1/07-8079
View
Type
Weiand D, Smith WC, Muzaffarullah S. Qualitative assessment of medication adherence at an urban leprosy outpatient clinic in Hyderabad, India. Leprosy review [Internet]. 2011;82(1):70-3. Available from: https://leprosyreview.org/article/82/1/07-0073
View
Type
Nardi SMT, Paschoal VD'arco, Zanetta DMT. Social participation of people affected by leprosy after discontinuation of multidrug therapy. Leprosy review [Internet]. 2011;82(1):55-64. Available from: https://leprosyreview.org/article/82/1/05-5064
View
Type
Sekar B, Arunagiri K, Kumar BN, Narayanan S, Menaka K, Oommen PK. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy. Leprosy review [Internet]. 2011;82(1):36-45. Available from: https://leprosyreview.org/article/82/1/03-6045
View
Type
Singh H, Nel B, Dey V, Tiwari P, Dulhani N. Adverse effects of multi-drug therapy in leprosy, a two years' experience (2006-2008) in tertiary health care centre in the tribal region of Chhattisgarh State (Bastar, Jagdalpur). Leprosy review [Internet]. 2011;82(1):17-24. Available from: https://leprosyreview.org/article/82/1/01-7024
View
Type
Declercq E. Reflections on the new WHO leprosy indicator: the rate of new cases with grade 2 disabilities per 100,000 population per year. Leprosy review [Internet]. 2011;82(1):3-5. Available from: https://leprosyreview.org/article/82/1/00-3005
View
Type
Lockwood DN. The different aspects of leprosy chemotherapy. Leprosy review. 2011;82(1):1-2.
View
Type
Vasconcelos LRS, Fonseca JPL, Carmo RF, Mendonça TF, Alves Pereira VR, Lucena-Silva N, et al. Mannose-binding lectin serum levels in patients with leprosy are influenced by age and MBL2 genotypes. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2011;15(8):e551-7.
View